Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen concentrate versus recombinant factor VIIa for bleeding control in elective CABG
PACTR201901535105039Completed
- Sponsor
- Ain Shams University Hospitals
- Start
- Nov 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of Fibrinogen human and coagulation factor VIIa in perioperative bleeding and coagulation defects (2 arms), sponsored by Ain Shams University Hospitals. Primary endpoint: Blood product transfusion requirement. Started Nov 2017; status: completed.
02
Drugs
Fibrinogen humancoagulation factor VIIa
03
Conditions
perioperative bleedingcoagulation defects
Beyond the preview
Go deeper on PACTR201901535105039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201901535105039.